Cencora, Inc. (AmerisourceBergen Corporation) 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on January 26, 2004. The report covers two primary events: the announcement of earnings for the fiscal quarter ended December 31, 2003, and the execution of a definitive agreement to acquire MedSelect, Inc.
Key Financial Metrics
The filing references a news release containing quarterly earnings results but does not explicitly state specific revenue, profit, cash flow, margin, debt, or liquidity figures within the text of this 8-K. The only specific financial metric disclosed in this document is the purchase price for the acquisition of MedSelect, Inc., totaling $13.4 million, which includes assumed debt.
Material Changes and Transactions
- Acquisition: The company signed a definitive agreement to purchase MedSelect, Inc., a privately held provider of automated medication and supply dispensing cabinets.
- Transaction Value: The purchase price is $13.4 million, inclusive of assumed debt.
- Timeline: The transaction is expected to close shortly following the January 26, 2004 announcement.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, forward-looking guidance, or a detailed discussion of risks and contingencies. It serves primarily as a notification that earnings results and the acquisition agreement have been announced via separate news releases (Exhibits 99.1 and 99.2), which are incorporated by reference.
Investor Verification Checklist
- Review Exhibit 99.1 for specific quarterly earnings figures (revenue, net income, EPS) for the period ended December 31, 2003.
- Verify the closing status and final terms of the MedSelect, Inc. acquisition.
- Confirm the impact of the $13.4 million acquisition on the company's balance sheet and cash flow.
- Check subsequent filings for any updates on the integration of MedSelect, Inc.